Chen‐Wen Lu
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Cholinesterase and Neurodegenerative Diseases 1
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Jong‐Kai Hsiao (6 shared papers)Hon‐Man Liu (5 shared papers)Yee‐Chun Chen (2 shared papers)Dongming Huang (2 shared papers)Ming Yao (2 shared papers)Chung‐Shi Yang (2 shared papers)Yu‐Shen Lin (1 shared paper)Chung‐Yuan Mou (1 shared paper)
- Journals
- Plants (4 papers)Evidence-based Complementary and Alternative Medicine (2 papers)Food Science & Nutrition (2 papers)Nutrients (1 paper)The FASEB Journal (1 paper)
- Partner nations
- Taiwan
In The Last Decade
Chen‐Wen Lu
16 papers receiving 325 citations
Peers
Comparison fields: 5 of 77
- Biomaterials 107
- Biomedical Engineering 119
- Genetics 24
- Developmental Neuroscience 8
- Materials Chemistry 96
Countries citing papers authored by Chen‐Wen Lu
This map shows the geographic impact of Chen‐Wen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Wen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Wen Lu more than expected).
Fields of papers citing papers by Chen‐Wen Lu
This network shows the impact of papers produced by Chen‐Wen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Wen Lu. The network helps show where Chen‐Wen Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen‐Wen Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 115 | |
| 2 | 2011 | 52 | |
| 3 | 2011 | 51 | |
| 4 | 2017 | 36 | |
| 5 | 2018 | 27 | |
| 6 | 2023 | 7 | |
| 7 | 2008 | 7 | |
| 8 | 2022 | 6 | |
| 9 | 2020 | 6 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 5 | |
| 12 | 2023 | 4 | |
| 13 | 2019 | 3 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 3 | |
| 16 | 2024 | 1 |
About Chen‐Wen Lu
Chen‐Wen Lu is a scholar working on Pharmacology, Biomaterials, Molecular Biology, Immunology and Biomedical Engineering, having authored 16 papers that have together received 331 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Lanthanide and Transition Metal Complexes (3 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Nanoplatforms for cancer theranostics (2 papers), Cerebrospinal fluid and hydrocephalus (1 paper), Alzheimer's disease research and treatments (1 paper), Muscle metabolism and nutrition (1 paper) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Biomaterials (107 citations), Biomedical Engineering (119 citations), Genetics (24 citations), Developmental Neuroscience (8 citations) and Materials Chemistry (96 citations). Chen‐Wen Lu has collaborated with scholars based in Taiwan. Frequent co-authors include Jong‐Kai Hsiao, Hon‐Man Liu, Yee‐Chun Chen, Dongming Huang, Ming Yao, Chung‐Shi Yang, Yu‐Shen Lin, Chung‐Yuan Mou, Si‐Han Wu and Yann Hung. Their work appears in journals such as Plants, Evidence-based Complementary and Alternative Medicine, Food Science & Nutrition, Nutrients and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.